Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palliare is a private medical device company focused on insufflation and surgical smoke evacuation technologies for minimally invasive procedures. Founded in 2018 as a spinout from Crospon, the company develops and commercializes products for laparoscopic, endoscopic, endoluminal, colorectal, and robotic surgery. Its core products include the EVA15 insufflator and smoke evacuation system, the EVA5 insufflator, and the EndoTrap device for staff protection during endoscopy and bronchoscopy. Palliare operates from Galway, Ireland, and Oceanside, California, and positions itself around safer operating-room environments and improved pressure control during minimally invasive procedures. The company appears to be a commercial-stage medtech business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palliare.